This Therapy Is REVERSING Terminal Cancer (Science-Backed Results)

This Therapy Is REVERSING Terminal Cancer (Science-Backed Results) 💕SUBSCRIBE: 👉 https://bit.ly/DrDreHealthTips ✅ SHARE on Facebook 👉 https://bit.ly/CureIsReal ━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ Goldman Sachs questioned whether CURING patients is profitable. Yet a scientist who lost his wife to cancer went on to save a dying 6-year-old girl with ZERO treatment options left. Coincidence? No! Discover the revolutionary CAR-T therapy achieving 75% cure rates in terminal patients and why the science train cannot be stopped, with Dr. Andre Wambier (Dr. Dre). ━━━━━━━━━━━━━━━━━━━━━━━━━━ In 2018, Goldman Sachs released a report asking if curing patients is sustainable for pharmaceutical revenue. Their example was devastating: Gilead developed a drug that cures over 90% of hepatitis C cases. Sales collapsed from 12 billion dollars to under 4 billion in just three years. Fewer sick people meant less transmission and fewer customers. The product destroyed its own market. This reveals a dark truth about modern healthcare that every cancer patient and family member needs to understand. But here is where hope enters the story. Dr. Carl June, an American immunologist, lost his wife to cancer in 1996. On her deathbed, he promised to find a cure. He stopped seeing clinic patients and dedicated everything to developing CAR-T therapy, a revolutionary treatment that takes your own immune cells, trains them to recognize tumors, and sends them back to attack the cancer. It is like training soldiers to recognize the enemy and sending them into battle. The results have been extraordinary. In 2012, Emily Whitehead became the first child treated with CAR-T. She was 6 years old with terminal leukemia and no options left. After a terrifying cytokine storm that nearly killed her, she woke up on her 7th birthday completely cancer-free. Today, more than 12 years later, she remains cured. Out of the first 12 terminal patients Dr. June treated, 9 achieved complete remission. That is a 75% cure rate for patients who had exhausted every other treatment. The CAR-T market now exceeds 4 billion dollars annually, proving that cures can be profitable too. ━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱️ CHAPTERS 00:00 Goldman Sachs asks: Is curing patients profitable? 01:01 The dark truth: Chronic treatment vs one-time cures 02:45 Dr. Carl June loses his wife to cancer 04:27 How CAR-T therapy works explained simply 05:32 2008 financial crisis cuts research funding 06:39 Bill Ludwig: First adult cured of terminal leukemia 07:44 Emily Whitehead: A dying 6-year-old with no hope 08:48 The cytokine storm that almost killed her 10:53 Emily wakes up cancer-free on her 7th birthday 12:14 Brazilian man cured through public healthcare 14:14 Why CAR-T costs $500,000 in America 15:20 Good news: Costs are falling rapidly 17:04 What you can do: Demand better from your doctor 19:39 Future cures: CRISPR, diabetes, solid tumors 21:52 The irony: CAR-T is now a $4 billion industry 23:19 Share this video with someone who needs hope ━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ DISCLAIMER: This video is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you or a loved one is facing a cancer diagnosis, terminal prognosis, or treatment decisions, seek guidance from qualified oncologists and medical professionals immediately. 📚 SCIENTIFIC REFERENCES Goldman Sachs 2018 Report on Gene Therapy: https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html FDA CAR-T Approval Information: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products Emily Whitehead Foundation: https://emilywhiteheadfoundation.org Human Genome Project Cost Analysis: https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost ━━━━━━━━━━━━━━━━━━━━━━━━━━ 👇 Subscribe for more essential health and safety guides! FOLLOW US ON OUR OTHER NETWORKS: ▶️ Main Channel: https://youtube.com/@DrDreHealthTips 🎦 Facebook: ht...